Cancer Family
Solid Neoplasm
CI-CAN-00000052Explore in graph →
Non-malignant1,822 active trials28 evidence items
- NCIt
- C9292
Loading cancer entity…
Cancer Family
CI-CAN-00000052Explore in graph →
Clinical trials
6,088 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04714086 | Expanded Access Program for Avapritinib | no longer available | — | — | Blueprint Medicines CorporationINDUSTRY | 0 | Oct 24, 2024 | clinicaltrials |
| NCT03914872 | Expanded Access Neoantigen Vaccine in Solid Tumors | no longer available | — | — | Washington University School of MedicineOTHER | 1 | Mar 12, 2024 | clinicaltrials |
| NCT05107193 | Afatinib (GILOTRIF®) in Patients Suffering From Tumors Harboring Neuregulin 1 (NRG1) Gene Alterations (Specifically NRG1 Gene Fusion-positive Advanced Solid Tumors) | no longer available | — | — | Boehringer IngelheimINDUSTRY | 0 | Nov 8, 2022 | clinicaltrials |
| NCT02354612 | Open Label Continuation Study of TRC105 for Patients Who Have Completed a Prior TRC105 Trial | no longer available | — | — | Tracon Pharmaceuticals Inc.INDUSTRY | 1 | Feb 15, 2021 | clinicaltrials |
| NCT04644107 | Expanded Access for Marizomib | no longer available | — | — | CelgeneINDUSTRY | 1 | Nov 25, 2020 | clinicaltrials |
| NCT01151930 | Long-Term Compassionate Use Study for Continued Administration of SCB01A-01 | no longer available | — | — | SynCore Biotechnology Co., Ltd.INDUSTRY | 0 | Nov 17, 2020 | clinicaltrials |
| NCT03702036 | Compassionate Use Individual Request Program for GSK525762 in NUT Midline Carcinoma | no longer available | — | — | GlaxoSmithKlineINDUSTRY | 0 | Apr 13, 2020 | clinicaltrials |
| NCT03554434 | An Expanded Access Program for AM0010 (Pegilodecakin) | no longer available | — | — | Eli Lilly and CompanyINDUSTRY | 0 | Mar 2, 2020 | clinicaltrials |
Data updated 22 days agoSource updated Oct 24, 2024source: clinicaltrials